USPTO serial 79052083
MOLMED
Reviewed by CopyMark Law Group
Reg. 3598704Status 706Registered
- Filing date
- Status date
- Registration date
- Mar 31, 2009
- Examiner
- DOMBROW, COLLEEN M
- Law office
- GENERIC WEB UPDATE
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with MOLMED?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
MOLECULAR MEDICINE S.p.A.; abbreviated MOLMED S.p.A.
Milano (MI), IT
Other trademarks owned by MOLECULAR MEDICINE S.p.A.; abbreviated MOLMED S.p.A.
MOLECULAR MEDICINE S.p.A.; abbreviated MOLMED S.p.A.
IT
Other trademarks owned by MOLECULAR MEDICINE S.p.A.; abbreviated MOLMED S.p.A.
MOLECULAR MEDICINE S.p.A.; abbreviated MOLMED S.p.A.
IT
Other trademarks owned by MOLECULAR MEDICINE S.p.A.; abbreviated MOLMED S.p.A.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stewart J. Bellus
Stewart J. Bellus Collard & Roe, P.C.1077 Northern Blvd.Roslyn, NY 11576UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry, namely, chemicals used in ex vivo manufacturing of active drug substances for use in respect to heamatological malignancies, solid tumors, infections and genetic diseases | ACTIVE | — |
| 005 | Pharmaceutical products for in vivo use in respect to heamatopoietic malignancies, solid tumors, angiogenic disorders, infections and genetic diseases | ACTIVE | — |
| 042 | Scientific research in the fields of heamatopoietic malignancies, cancer, infections, angiogenesis and genetic diseases, quality assurance services, namely, consultant services in the field of pharmaceutical preparation development; pharmaceutical drug development services, providing quality control and quality assurance services for others in the field of pharmaceuticals; regulatory and quality aspects, namely, providing quality assurance services in the field of pharmaceutical preparations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MOLECULAR MEDICINE S.p.A.; abbreviated MOLMED S.p.A.
- Other trademarks owned by MOLECULAR MEDICINE S.p.A.; abbreviated MOLMED S.p.A.
- Other trademarks owned by MOLECULAR MEDICINE S.p.A.; abbreviated MOLMED S.p.A.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named MOLMED
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 27, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 14, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 1, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 27, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 17, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 26, 2019 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Apr 26, 2019 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Apr 16, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 28, 2019 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Nov 9, 2017 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Mar 4, 2015 | NA15 | SEC. 15 ACKNOWLEDGEMENT - MAILED | — |
| Mar 4, 2015 | 15AK | REGISTERED - SEC. 15 ACKNOWLEDGED | — |
| Mar 2, 2015 | E15R | TEAS SECTION 15 RECEIVED | — |
| Feb 21, 2015 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED | — |
| Feb 21, 2015 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Feb 21, 2015 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 17, 2015 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jan 23, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 23, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 12, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 14, 2009 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 14, 2009 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 30, 2009 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 31, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 13, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 24, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 5, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 5, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 28, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 28, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 28, 2008 | ALIE | ASSIGNED TO LIE | — |
| Nov 17, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 28, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 30, 2008 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 15, 2008 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 14, 2008 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 14, 2008 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 13, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| May 9, 2008 | NWAP | NEW APPLICATION ENTERED | — |
| May 8, 2008 | LIMS | LIMITATION OF GOODS/SERVICES FROM IB ENTERED | — |
| May 8, 2008 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |